Back to Market返回行情

PBH Prestige Consumer Healthcare Inc.

USHealthcare
$48.29-4.22%ClosedMarket Cap: $2.29B

As of 2026-07-08 16:00

Why PBH matters now

Prestige Consumer Healthcare Inc. (PBH) is a US stock in Healthcare. The latest InvestLog snapshot shows $48.29 with -4.22% on the session and $2.29B in market capitalization; recent performance reads 1-month +1.14% and YTD -23.86%.

The latest financial table shown here is Q4 2026, with revenue of $281.6M, net income of $53.9M, and EPS of $1.13. Investors can compare that operating picture with valuation signals such as P/E 14.34 and FCF yield 11.4%.

The latest indexable market news headline is "Is the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Buy with a median target of $66.00; recent insider activity includes Sacco Christine filing F-InKind. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

14.34

PEG

P/B

1.18

P/S

2.04

EV/EBITDA

9.68

DCF Value

$341.90

FCF Yield

11.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

54.0%

Operating Margin

28.4%

Net Margin

17.5%

ROE

10.3%

ROA

5.4%

ROIC

6.6%

Financials

PeriodRevenueNet IncomeEPS
Q4 2026$281.6M$53.9M$1.13
FY 2026$1.09B$190.3M$3.91
Q3 2026$283.4M$46.7M$0.97
Q2 2026$274.1M$42.2M$0.86

Analyst Ratings

Consensus

Buy

Target (Consensus)

$66.00

Target (Median)

$66.00

Target Range

$66.00 - $66.00

Strong Buy: 0Buy: 5Hold: 2Sell: 0Strong Sell: 0
Canaccord GenuityBuy
2026-05-15
OppenheimerPerform
2026-05-14
OppenheimerOutperform
2026-05-07
JefferiesHold
2026-02-02
Canaccord GenuityBuy
2025-11-07

Trading Activity

Insider Trades

Sacco Christineofficer: CFO & COO
Sell2026-05-14
Zerillo Jeffreyofficer: Senior VP Operations
Sell2026-05-12
Mekhail Adelofficer: EVP, Marketing & Sales
Sell2026-05-11
Lombardi Ronald M.director, officer: Chief Executive Officer
Sell2026-05-11
Sacco Christineofficer: CFO & COO
Sell2026-05-11

Company Info

Sector

Healthcare

Industry

Medical - Distribution

Country

US

Exchange

Beta

0.35

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.